Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00130442
Status:
COMPLETED
Last Update Posted:
2022-06-23
First Post:
2005-08-12
Brief Title:
Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma
Sponsor:
Cellxpert Biotechnology Corp
Organization:
Cellxpert Biotechnology Corp
Organization Data
Organization:
Cellxpert Biotechnology Corp
Class:
INDUSTRY
Study ID:
PR88205
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cellxpert Biotechnology Corp
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Medigen Biotechnology Corporation | INDUSTRY |